Regulatory Perspectives on Qualification of Biomarkers for Drug Development
Time: 11:00 am
day: Day Two
Details:
- Understanding the different ways biomarkers can be utilized in drug development
- Recognizing the different pathways that a biomarker can be qualified for use in drug development
- Facilitating collaboration between researchers, industry, and patient advocacy groups to enable development of biomarkers to address areas of unmet need
